-+ 0.00%
-+ 0.00%
-+ 0.00%

INVESTIGATIONAL ONCE-WEEKLY ORAL HIV TREATMENT REGIMEN OF ISLATRAVIR AND LENACAPAVIR MAINTAINED VIROLOGICAL SUPPRESSION IN ADULTS WITH HIV WHO SWITCHED ANTIRETROVIRAL THERAPY

Reuters·07/21/2026 14:00:06

Please log in to view news